US Patent Issued to InCarda Therapeutics on March 17 for "Antiarrhythmic formulation" (California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,073, issued on March 17, was assigned to InCarda Therapeutics Inc. (West Jordan, Utah).

"Antiarrhythmic formulation" was invented by Michael Laird Hurrey (San Ramon, Calif.), Luiz Belardinelli (Palo Alto, Calif.), Prashanti Madhavapeddi (Fremont, Calif.) and Carlos Schuler (Kensington, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions comprising an antiarrhythmic agent for treatment of a heart condition via inhalation. Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product an...